Log in to save to my catalogue

136 Sentinel lymph node mapping in early-stage ovarian cancer: equivalence of cervix vs utero-ovaria...

136 Sentinel lymph node mapping in early-stage ovarian cancer: equivalence of cervix vs utero-ovaria...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2954456737

136 Sentinel lymph node mapping in early-stage ovarian cancer: equivalence of cervix vs utero-ovarian ligament injection for pelvic sentinel lymph node mapping

About this item

Full title

136 Sentinel lymph node mapping in early-stage ovarian cancer: equivalence of cervix vs utero-ovarian ligament injection for pelvic sentinel lymph node mapping

Publisher

Kidlington: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A579-A579

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Introduction/BackgroundLymph nodes metastases occurs in approximately 14% (range 6–30%) of early-stage ovarian cancer and determines severely its evolution and prognostic. Surgical management of ovarian cancer in an apparent early stage includes pelvic and para-aortic lymphadenectomy, which is associated with characteristic complications, such as l...

Alternative Titles

Full title

136 Sentinel lymph node mapping in early-stage ovarian cancer: equivalence of cervix vs utero-ovarian ligament injection for pelvic sentinel lymph node mapping

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2954456737

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2954456737

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2024-ESGO.1126

How to access this item